Keyphrases
Biomarker Panel
100%
MS Relapse
100%
Relapsing-remitting multiple Sclerosis
100%
Neurofilament Light (NF-L)
100%
ELTD1
100%
SCAT5
100%
College Students
100%
Aged Persons
100%
Multiple Sclerosis
100%
Experimental Autoimmune Encephalomyelitis
100%
Molecular Targets
100%
Remission
57%
Memorization
40%
Treatment Process
40%
Diagnostic Process
40%
Healthcare Professionals
40%
Concussion
40%
Glioblastoma
37%
Multiple Sclerosis Relapse
28%
Blood Proteins
28%
Multiple Sclerosis Treatment
28%
Central Nervous System
25%
Return to Play
20%
Robust Set
20%
Recovery Process
20%
Injury Definition
20%
Normative Dataset
20%
Balance Testing
20%
Baseline Testing
20%
Non-athletes
20%
Sports Industry
20%
Concussion Diagnosis
20%
Standardized Tool
20%
Diagnosis Treatment
20%
DSG3
14%
Clinical MRI
14%
Biomarker Development
14%
Protein Panel
14%
Differentially Abundant
14%
Disease Activity
14%
Logistic Regression Model
14%
Logistic Regression
14%
Multiplex
14%
T-test
14%
Clinical Manifestations
14%
Inflammatory Activity
14%
Promising Biomarkers
12%
Antibody Therapy
12%
Latrophilin
12%
Regional Cerebral Blood Flow (rCBF)
12%
Biochemistry, Genetics and Molecular Biology
Experimental Mouse
100%
Prevalence
100%
Cross Sectional Study
100%
Chromosome 1
100%
RNA Sequencing
100%
Blood Brain Barrier
100%
Tumor Volume
100%
Angiogenesis
100%
Transmembrane Domain
100%
Perfusion
100%
Brain Blood Flow
100%
Synapsin I
100%
Epidermal Growth Factor
100%
Vascularization
100%
Mouse Model
100%
Neurofilament Light
100%
Immunology and Microbiology
Relapsing Remitting Multiple Sclerosis
100%
Neurofilament
100%
Light Chain
100%
Experimental Autoimmune Encephalomyelitis
100%
Multiple Sclerosis
100%
Central Nervous System
60%
Magnetic Resonance Imaging
54%
Immunology
40%
RNA Sequencing
20%
Chromosome 1
20%
Xenograft
20%
Brain Blood Flow
20%
Corpus Callosum
20%
Cervical Spinal Cord
20%
Tumor Volume
20%
Perfusion
20%
Angiogenesis
20%
Vascularization
20%
Mouse Model
20%
Epidermal Growth Factor
20%
Blood Brain Barrier
20%